An enhanced flux of glucose through glycolysis is maintained by AKT-dependent upregulation of hexokinase II and phosphofructokinase [5], whereas the glycolytic cascade is slowed down by overexpression of low-activity dimeric form of PKM2 in cancer cells [6,7]. The gene discussed is AKT1; the disease is cancer.